Medicare Enrolled

Dr. Daniel Agarwal, M.D.

Ophthalmology · San Luis Obispo, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
689 TANK FARM RD, San Luis Obispo, CA 93401
8057813937
In practice since 2013 (13 years)
NPI: 1811230766 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agarwal

Dr. Daniel Agarwal is an ophthalmology specialist in San Luis Obispo, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Agarwal performed 39,298 Medicare services across 3,043 unique beneficiaries.

Between the years covered by Open Payments, Dr. Agarwal received a total of $12,798 from 20 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 2% volume in CA $12,798 industry payments

Medicare Practice Summary

Medicare Utilization ↗
39,298
Medicare services
Top 2% in CA for ophthalmology
3,043
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,023 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
30,540 $29 $47
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,799 $33 $93
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,528 $101 $145
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,445 $91 $400
Aflibercept eye injection (Eylea) 1,230 $694 $988
Injection, ranibizumab, 0.1 mg 573 $182 $480
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
417 $61 $105
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
219 $120 $293
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
117 $72 $95
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
99 $30 $140
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $122 $185
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
69 $19 $50
Removal of eye fluid 48 $97 $273
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
28 $38 $190
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
23 $47 $95
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
21 $134 $199
Removal of retinal membrane
A surgical procedure to remove a membrane from the surface of the retina.
16 $954 $2,899
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
16 $48 $158
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
15 $209 $700
New patient office visit, complex (60-74 min) 11 $169 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,798
Total received (2018-2024)
Avg $1,828/year across 7 years
Top 12% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,633 (51.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,164 (48.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,270
2023
$953
2022
$624
2021
$2,393
2020
$2,290
2019
$1,564
2018
$1,703

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$2,701
Regeneron Healthcare Solutions, Inc.
$245
Glaukos Corporation
$133
Apellis Pharmaceuticals, Inc.
$119
Dompe US, Inc.
$28
Astellas Pharma US Inc
$23
Alimera Sciences, Inc.
$19
Top 3 companies account for 94.2% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$3,463
Genentech USA, Inc.
$3,173
Regeneron Pharmaceuticals, Inc.
$2,619
Regeneron Healthcare Solutions, Inc.
$1,144
Alcon Vision LLC
$484
Apellis Pharmaceuticals, Inc.
$372
Glaukos Corporation
$341
Alcon Research Ltd
$302
Astellas Pharma US Inc
$144
Novartis Pharmaceuticals Corporation
$125
AbbVie Inc.
$123
SUN PHARMACEUTICAL INDUSTRIES INC.
$117
Allergan Inc.
$93
AbbVie, Inc.
$84
Bausch & Lomb, a division of Bausch Health US, LLC
$62
Kala Pharmaceuticals, Inc.
$59
Dompe US, Inc.
$28
EyePoint Pharmaceuticals US, Inc.
$24
Novo Nordisk Inc
$21
Alimera Sciences, Inc.
$19
Top 3 companies account for 72.3% of all-time payments
Associated products mentioned in payments ›
AcrySof · AcrySof IQ PanOptix · BEOVU · Cequa · Clareon · Constellation · DEXYCU · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · INVELTYS · Izervay · Lucentis · NGENUITY · OXERVATE · OZURDEX · Rybelsus · SUSVIMO · Syfovre · VABYSMO · VISUDYNE · Vabysmo · YUTIQ · iDose · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in San Luis Obispo?
Compare ophthalmologists in the San Luis Obispo area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
23
Per 100K population
8.2
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agarwal is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 12% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agarwal experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Agarwal performed 30,540 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $12,798 from 20 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other ophthalmologists in San Luis Obispo?
Dr. Agarwal's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →